Breaking News Instant updates and real-time market news.

2020-11-30 06:19:57 LII Lennox $289.58 / +0.875 (+0.30%) 06:19 11/30/20 11/30 06:19 11/30/20 06:19	Lennox downgraded to Equal Weight on valuation at Barclays Barclays analyst Julian Mitchell downgraded Lennox to Equal Weight from Overweight with an unchanged price target of $300. The analyst also downgraded the firm's U.S. Multi-Industry view to Neutral from Positive as part of its 2021 outlook. Lennox is trading at the high end of its relative valuation range to history versus peers, and a "sharp" cyclical revenue recovery appears well factored into Street estimates, "while the scope for self-help looks somewhat limited," Mitchell tells investors in a research note.	02 Dec
LII Lennox $289.58 / +0.875 (+0.30%) 11/30/20 Barclays Lennox downgraded to Equal Weight from Overweight at Barclays 11/19/20 Goldman Sachs Lennox downgraded to Sell from Neutral at Goldman Sachs 10/20/20 Credit Suisse Lennox price target raised to $281 from $257 at Credit Suisse 10/20/20 Morgan Stanley Lennox price target raised to $227 from $208 at Morgan Stanley

2020-11-30 06:19:57

LII

Lennox

$289.58 / +0.875 (+0.30%)

06:19

11/30/20

11/30

06:19

11/30/20

06:19

Lennox downgraded to Equal Weight on valuation at Barclays

Barclays analyst Julian Mitchell downgraded Lennox to Equal Weight from Overweight with an unchanged price target of $300. The analyst also downgraded the firm's U.S. Multi-Industry view to Neutral from Positive as part of its 2021 outlook. Lennox is trading at the high end of its relative valuation range to history versus peers, and a "sharp" cyclical revenue recovery appears well factored into Street estimates, "while the scope for self-help looks somewhat limited," Mitchell tells investors in a research note.

02
Dec

LII Lennox

$289.58 / +0.875 (+0.30%)

11/30/20 Barclays: Lennox downgraded to Equal Weight from Overweight at Barclays

11/19/20 Goldman Sachs: Lennox downgraded to Sell from Neutral at Goldman Sachs

10/20/20 Credit Suisse: Lennox price target raised to $281 from $257 at Credit Suisse

10/20/20 Morgan Stanley: Lennox price target raised to $227 from $208 at Morgan Stanley

TODAY'S FREE FLY STORIES

Upgrade	Obsidian Energy upgraded to Market Perform from Underperform at Raymond James » 09:39 01/15/21 01/15 09:39 01/15/21 09:39 OBE Obsidian Energy $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Initiation	CNX Resources initiated with an Overweight at JPMorgan » 09:38 01/15/21 01/15 09:38 01/15/21 09:38 CNX CNX Resources / + JPMorgan analyst Zach… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CNX CNX Resources / + 11/16/20 Einhorn's Greenlight buys Twitter, exits Whirlpool in Q3 10/22/20 CNX Resources rises after Bloomberg reports on EQT takeover interest 10/22/20 CNX Resources jumps 16% to $11.99 after Bloomberg report of EQT bid 09/28/20 CNX Resources, CNX Midstream Partners announce completion of merger CNX CNX Resources / + 12/15/20 BofA CNX Resources initiated with a Neutral at BofA 12/15/20 BofA CNX Resources initiated with a Neutral at BofA 10/30/20 MKM Partners CNX Resources upgraded to Buy from Neutral at MKM Partners 10/30/20 MKM Partners CNX Resources upgraded to Buy from Neutral at MKM Partners CNX CNX Resources / + 07/30/20 CNX Resources reports Q2 EPS (78c), consensus 2c CNX CNX Resources / + 10/22/20 EQT pursuing acquisition of CNX Resources, Bloomberg reports 10/22/20 EQT recently made takeover proposal to CNX Resources, Bloomberg says 10/22/20 EQT said to pursue acquisition of CNX Resources, Bloomberg reports CNX CNX Resources / + 10/23/20 Fly Intel: Pre-market Movers 10/22/20 Fly Intel: Wall Street's top stories for Thursday 07/27/20 Fly Intel: Wall Street's top stories for July 27 07/27/20 Fly Intel: Wall Street's top stories at midday 01/28/21 CNX Resources - CNX CNX CNX Resources / + 07/21/20 CNX Resources put volume heavy and directionally bearish
Recommendations	Albertsons price target raised to $21 after Q3 report at Northcoast » 09:38 01/15/21 01/15 09:38 01/15/21 09:38 ACI Albertsons $17.47 / +0.36 (+2.10%) Northcoast analyst Chuck… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACI Albertsons $17.47 / +0.36 (+2.10%) 11/30/20 Albertsons associates ratify agreement with UFCW local unions 11/24/20 Albertsons implements contactless temperature, health screening 11/19/20 Albertsons incorporates SNAP EBT payments at Drive Up & Go locations 11/12/20 Albertsons to partner with HHS to provide COVID-19 vaccine ACI Albertsons $17.47 / +0.36 (+2.10%) 01/12/21 BMO Capital Albertsons downgraded to Market Perform from Outperform at BMO Capital 01/07/21 Barclays Albertsons downgraded to Underweight from Equal Weight at Barclays 01/06/21 Deutsche Bank Albertsons price target raised to $24 from $22 at Deutsche Bank 12/04/20 R5 Capital Kroger downgraded to Hold after earnings at R5 Capital ACI Albertsons $17.47 / +0.36 (+2.10%) 01/12/21 Albertsons raises FY20 adjusted EPS view to $3.05-$3.15 from $2.75-$2.85 01/12/21 Albertsons reports Q3 adjusted EPS 66c, consensus 42c 01/11/21 Notable companies reporting before tomorrow's open 01/11/21 Notable companies reporting before tomorrow's open 26 Jun ACI Albertsons $17.47 / +0.36 (+2.10%) 09/19/20 Albertsons a Buy as stock looks cheap, Barron's says ACI Albertsons $17.47 / +0.36 (+2.10%) 01/12/21 Fly Intel: Pre-market Movers 11/09/20 Fly Intel: What to watch in Beyond Meat earnings report 10/20/20 Fly Intel: Pre-market Movers 10/14/20 Fly Intel: After-Hours Movers ACI Albertsons $17.47 / +0.36 (+2.10%) 01/13/21 Largest borrow rate increases among liquid names 01/12/21 Largest borrow rate increases among liquid names 01/11/21 Largest borrow rate increases among liquid names 01/07/21 Largest borrow rate increases among liquid names
Upgrade	Vermilion Energy upgraded to Outperform from Market Perform at Raymond James » 09:38 01/15/21 01/15 09:38 01/15/21 09:38 VET Vermilion Energy $5.45 / +0.25 (+4.81%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VET Vermilion Energy $5.45 / +0.25 (+4.81%) 11/17/20 Vermilion Energy announces changes to its leadership team 09/24/20 Vermilion Energy provides update on Total's Grandpuits refinery conversion VET Vermilion Energy $5.45 / +0.25 (+4.81%) 01/14/21 Scotiabank Vermilion Energy price target raised to C$8.50 from C$8 at Scotiabank 01/06/21 National Bank Vermilion Energy price target raised to C$7 from C$4.75 at National Bank 12/16/20 CIBC Vermilion Energy price target raised to C$7 from C$6 at CIBC 12/08/20 JPMorgan Vermilion Energy downgraded to Underweight on leverage at JPMorgan VET Vermilion Energy $5.45 / +0.25 (+4.81%) 11/09/20 Vermilion Energy reports Q3 FFO 73c vs. $1.39 last year 07/27/20 Vermilion Energy reports Q2 FFO 52c vs. $1.09 last year
Upgrade	Baytex Energy upgraded to Market Perform from Underperform at Raymond James » 09:37 01/15/21 01/15 09:37 01/15/21 09:37 BTE Baytex Energy $0.52 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BTE Baytex Energy $0.52 / + (+0.00%) 12/03/20 Baytex Energy trading halted, news pending 12/02/20 Baytex Energy approves 2021 capital budget of $225M-$275M 11/02/20 Baytex Energy sees FY20 average production 80,000 boe/d BTE Baytex Energy $0.52 / + (+0.00%) 12/04/20 TD Securities Baytex Energy price target raised to C$0.75 from C$0.55 at TD Securities 12/03/20 Raymond James Baytex Energy price target raised to C$0.70 from C$0.50 at Raymond James 12/03/20 BMO Capital Baytex Energy price target raised to C$0.75 from C$0.60 at BMO Capital 12/03/20 Canaccord Baytex Energy price target raised to C$0.75 from C$0.60 at Canaccord BTE Baytex Energy $0.52 / + (+0.00%) 11/02/20 Baytex Energy reports Q3 EPS (4c), consensus (11c) 07/29/20 Baytex Energy reports Q2 EPS (25c) vs. 14c a year ago BTE Baytex Energy $0.52 / + (+0.00%) 12/07/20 Four new option listings and one option delisting on December 7th

Recommendations	CF Industries price target raised to $52 from $38 at JPMorgan » 09:37 01/15/21 01/15 09:37 01/15/21 09:37 CF CF Industries $45.32 / -0.03 (-0.07%) JPMorgan analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options CF CF Industries $45.32 / -0.03 (-0.07%) 11/04/20 CF Industries sees 2021 global nitrogen market consistent with recent years 10/19/20 CF Industries appoints Julie Scheck Freigang as chief information officer CF CF Industries $45.32 / -0.03 (-0.07%) 07:39 Today RBC Capital CF Industries price target raised to $45 from $40 at RBC Capital 01/12/21 Cleveland Research CF Industries upgraded to Buy on improved setup at Cleveland Research 01/12/21 Cleveland Research CF Industries upgraded to Buy from Neutral at Cleveland Research 12/15/20 RBC Capital CF Industries price target raised to $40 from $30 at RBC Capital CF CF Industries $45.32 / -0.03 (-0.07%) 11/04/20 CF Industries reports Q3 EPS (13c), consensus 7c 11/04/20 Notable companies reporting after market close 08/05/20 CF Industries reports Q2 EPS 89c, consensus 65c 08/05/20 Notable companies reporting after market close CF CF Industries $45.32 / -0.03 (-0.07%) 09/17/20 Trump to announce $13B in relief to farmers, Reuters reports CF CF Industries $45.32 / -0.03 (-0.07%) 12/28/20 Early notable gainers among liquid option names on December 28th 11/27/20 Early notable gainers among liquid option names on November 27th 11/06/20 CF Industries call volume above normal and directionally bullish 09/28/20 Largest borrow rate increases among liquid names
Upgrade	Cardinal Energy upgraded to Market Perform from Underperform at Raymond James » 09:36 01/15/21 01/15 09:36 01/15/21 09:36 CRLFF Cardinal Energy $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CRLFF Cardinal Energy $0.00 / + (+0.00%) 11/06/20 Stifel Cardinal Energy price target lowered to C$0.75 from C$1.00 at Stifel 03/19/20 Stifel Cardinal Energy downgraded to Hold from Buy at Stifel 03/13/20 TD Securities Cardinal Energy price target lowered to C$0.60 from C$3.25 at TD Securities
Recommendations	Mosaic price target raised to $34 from $32 at JPMorgan » 09:35 01/15/21 01/15 09:35 01/15/21 09:35 MOS Mosaic $28.88 / +0.78 (+2.78%) JPMorgan analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MOS Mosaic $28.88 / +0.78 (+2.78%) 12/14/20 Mosaic announces November potash sales revenue, volume 12/09/20 Mosaic announces agreement with BioConsortia to develop microbial products 11/24/20 Mosaic reports Commerce's preliminary countervailing duty determinations 11/24/20 Commerce reports 'affirmative preliminary determinations' in Mosaic CVD case MOS Mosaic $28.88 / +0.78 (+2.78%) 08:15 Today RBC Capital Mosaic price target raised to $35 from $32 at RBC Capital 01/07/21 JPMorgan JPMorgan upgrades 'most inexpensive' Mosaic to Overweight 01/07/21 JPMorgan Mosaic upgraded to Overweight from Neutral at JPMorgan 12/15/20 RBC Capital Mosaic price target raised to $32 from $25 at RBC Capital MOS Mosaic $28.88 / +0.78 (+2.78%) 11/02/20 Mosaic reports Q3 EPS 23c, consensus 17c 11/02/20 Notable companies reporting after market close 08/03/20 Mosaic reports Q2 adj. EPS 11c, consensus (1c) 08/03/20 Notable companies reporting after market close MOS Mosaic $28.88 / +0.78 (+2.78%) 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/03/20 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: After-Hours Movers 03/11/21 The Mosaic Company MOS Mosaic $28.88 / +0.78 (+2.78%) 12/14/20 Early notable gainers among liquid option names on December 14th 11/17/20 Unusually active option classes on open November 17th 11/16/20 Mosaic put volume heavy and directionally bearish 11/11/20 Mosaic put volume heavy and directionally bearish
Upgrade	Vertical Research upgrades Delta to Buy, sees potential triple in next 5 years » 09:35 01/15/21 01/15 09:35 01/15/21 09:35 DAL Delta Air Lines $41.46 / +1.03 (+2.55%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Delta Air Lines doesn't see Covid-19 testing on domestic flights 01/14/21 Delta Air Lines 'generating a meaningful premium' with blocked middle seats 01/14/21 Delta Air Lines sees 34 aircraft deliveries in 2021, total CapEx of $1.3B 01/14/21 Delta Air Lines sees sustained travel recovery starting in 2H21 DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 09:27 Today Vertical Research Delta Air Lines upgraded to Buy from Hold at Vertical Research 07:24 Today Morgan Stanley Delta Air Lines price target raised to $55 from $51 at Morgan Stanley 01/14/21 Fly Intel: Top five analyst downgrades 01/14/21 Susquehanna Susquehanna cuts Delta to Neutral on international and business travel risks DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Delta Air Lines sees Q1 revenue down 60%-65%, consensus $4.46B 01/14/21 Delta Air Lines reports Q4 adjusted EPS ($2.53), consensus ($2.51) 01/13/21 Notable companies reporting before tomorrow's open 10/13/20 Delta Air Lines sees Q4 revenue down 65%-70% from last year DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Delta, United, Alaska prohibit guns in checked bags for D.C. flights, AP says 01/12/21 U.S. to expand proof of no COVID rule to all international visitors, WSJ says 01/04/21 Major airlines back expanding COVID testing for more travelers, Reuters reports 01/04/21 Delta CEO sees positive cash flow by spring, AP reports DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/14/21 Fly Intel: Pre-market Movers 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 12/28/20 Delta Air Lines call volume above normal and directionally bullish 09/16/20 Delta Air Lines call volume above normal and directionally bullish 09/15/20 Early notable gainers among liquid option names on September 15th 09/15/20 Unusually active option classes on open September 15th
Upgrade	United Overseas Bank upgraded to Overweight from Neutral at JPMorgan » 09:33 01/15/21 01/15 09:33 01/15/21 09:33 UOVEY United Overseas Bank $0.00 / + (+0.00%) JPMorgan analyst Harsh… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research UOVEY United Overseas Bank $0.00 / + (+0.00%) 11/20/20 JPMorgan United Overseas Bank downgraded to Neutral from Overweight at JPMorgan 11/18/20 Jefferies United Overseas Bank upgraded to Buy from Hold at Jefferies 02/21/20 Jefferies United Overseas Bank downgraded to Hold from Buy at Jefferies

Hot Stocks	Biomerica expects completion of enrollment in IBS trial by end of April » 09:33 01/15/21 01/15 09:33 01/15/21 09:33 BMRA Biomerica $6.06 / -0.25 (-3.96%) The Company is nearing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BMRA Biomerica $6.06 / -0.25 (-3.96%) 09:31 Today Biomerica to begin marketing antigen rapid test in Europe 09:30 Today Biomerica says FDA actively reviewing EUA application for COVID-19 test 01/12/21 Biomerica COVID-19 antigen rapid test receives CE Mark 12/09/20 Biomerica nears completion of enrollment in InFoods IBS DGT trial BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/12/21 B. Riley Securities Biomerica price target lowered to $10 from $11 at B. Riley Securities 11/10/20 Colliers Biomerica initiated with a Buy at Colliers 06/05/20 B. Riley FBR Biomerica price target raised to $11 from $6.25 at B. Riley FBR BMRA Biomerica $6.06 / -0.25 (-3.96%) 09:29 Today Biomerica reports Q2 revenue $1.37M, consensus $2.5M 10/16/20 Biomerica reports Q1 revenue $1.14M, two est. $1.2M BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/14/21 Biomerica Inc options imply 14.5% move in share price post-earnings 08/28/20 Biomerica Inc options imply 21.1% move in share price post-earnings 07/29/20 Thirteen new option listings on July 29th
Upgrade	TMB Bank upgraded to Overweight from Neutral at JPMorgan » 09:32 01/15/21 01/15 09:32 01/15/21 09:32 TMBBY TMB Bank / + JPMorgan analyst Harsh… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Upgrade	Chemtrade Logistics upgraded to Outperform from Market Perform at Raymond James » 09:32 01/15/21 01/15 09:32 01/15/21 09:32 CGIFF Chemtrade Logistics $0.00 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CGIFF Chemtrade Logistics $0.00 / + (+0.00%) 12/21/20 CIBC Chemtrade Logistics upgraded to Outperformer from Neutral at CIBC 11/16/20 BMO Capital Chemtrade Logistics price target lowered to C$6 from C$6.50 at BMO Capital 11/16/20 National Bank Chemtrade Logistics price target lowered to C$5.50 from C$6.25 at National Bank 11/16/20 Scotiabank Chemtrade Logistics price target lowered to C$6 from C$7 at Scotiabank
Hot Stocks	Biomerica to begin marketing antigen rapid test in Europe » 09:31 01/15/21 01/15 09:31 01/15/21 09:31 BMRA Biomerica $6.06 / -0.25 (-3.96%) The Company also recently… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BMRA Biomerica $6.06 / -0.25 (-3.96%) 09:30 Today Biomerica says FDA actively reviewing EUA application for COVID-19 test 01/12/21 Biomerica COVID-19 antigen rapid test receives CE Mark 12/09/20 Biomerica nears completion of enrollment in InFoods IBS DGT trial 09/01/20 Biomerica Inc reports FY20 revenue $6.7M, consensus $5.65M BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/12/21 B. Riley Securities Biomerica price target lowered to $10 from $11 at B. Riley Securities 11/10/20 Colliers Biomerica initiated with a Buy at Colliers 06/05/20 B. Riley FBR Biomerica price target raised to $11 from $6.25 at B. Riley FBR BMRA Biomerica $6.06 / -0.25 (-3.96%) 09:29 Today Biomerica reports Q2 revenue $1.37M, consensus $2.5M 10/16/20 Biomerica reports Q1 revenue $1.14M, two est. $1.2M BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/14/21 Biomerica Inc options imply 14.5% move in share price post-earnings 08/28/20 Biomerica Inc options imply 21.1% move in share price post-earnings 07/29/20 Thirteen new option listings on July 29th
Recommendations	TTM Technologies price target raised to $16 from $15 at Truist » 09:30 01/15/21 01/15 09:30 01/15/21 09:30 TTMI TTM Technologies $14.23 / +0.1 (+0.71%) Truist analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events TTMI TTM Technologies $14.23 / +0.1 (+0.71%) 09/29/20 Craig-Hallum Craig-Hallum bullish on TTM Technologies, initiates with a Buy 09/29/20 Craig-Hallum TTM Technologies initiated with a Buy at Craig-Hallum 09/21/20 SMBC Nikko TTM Technologies initiated with an Outperform at SMBC Nikko 07/02/20 Needham TTM Technologies upgraded to Buy from Hold at Needham TTMI TTM Technologies $14.23 / +0.1 (+0.71%) 10/28/20 TTM Technologies sees Q4 EPS 22c-28c, consensus 24c 10/28/20 TTM Technologies reports Q3 EPS 25c, consensus 19c 07/29/20 TTM Technologies sees 3Q EPS 16c-22c, consensus 15c 07/29/20 TTM Technologies reports Q2 EPS 31c, consensus 14c 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 02/03/21 TTM Technologies - TTMI

Hot Stocks	Biomerica says FDA actively reviewing EUA application for COVID-19 test » 09:30 01/15/21 01/15 09:30 01/15/21 09:30 BMRA Biomerica $6.06 / -0.25 (-3.96%) The Company announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/12/21 Biomerica COVID-19 antigen rapid test receives CE Mark 12/09/20 Biomerica nears completion of enrollment in InFoods IBS DGT trial 09/01/20 Biomerica Inc reports FY20 revenue $6.7M, consensus $5.65M 08/31/20 Biomerica discloses SEC investigation related to COVID-19 Rapid Test samples BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/12/21 B. Riley Securities Biomerica price target lowered to $10 from $11 at B. Riley Securities 11/10/20 Colliers Biomerica initiated with a Buy at Colliers 06/05/20 B. Riley FBR Biomerica price target raised to $11 from $6.25 at B. Riley FBR BMRA Biomerica $6.06 / -0.25 (-3.96%) 09:29 Today Biomerica reports Q2 revenue $1.37M, consensus $2.5M 10/16/20 Biomerica reports Q1 revenue $1.14M, two est. $1.2M BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/14/21 Biomerica Inc options imply 14.5% move in share price post-earnings 08/28/20 Biomerica Inc options imply 21.1% move in share price post-earnings 07/29/20 Thirteen new option listings on July 29th
Recommendations	Union Pacific price target raised to $250 from $220 at Raymond James » 09:30 01/15/21 01/15 09:30 01/15/21 09:30 UNP Union Pacific $216.16 / -0.51 (-0.24%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UNP Union Pacific $216.16 / -0.51 (-0.24%) 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/10/21 Fly Intel: Top five weekend stock stories 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 UNP Union Pacific $216.16 / -0.51 (-0.24%) 01/12/21 JPMorgan Union Pacific price target raised to $216 from $212 at JPMorgan 01/11/21 Bernstein Union Pacific upgraded to Outperform from Market Perform at Bernstein 01/11/21 BMO Capital Union Pacific price target raised to $230 from $220 at BMO Capital 01/11/21 Citi Union Pacific price target raised to $250 from $215 at Citi UNP Union Pacific $216.16 / -0.51 (-0.24%) 10/22/20 Union Pacific reports Q3 EPS $2.01, consensus $2.05 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open 07/23/20 Union Pacific reports Q2 EPS $1.67, consensus $1.55 UNP Union Pacific $216.16 / -0.51 (-0.24%) 01/09/21 Some century-old stocks still deliver, Barron's says 08/14/20 Union Pacific issues second spot rate increase in California, JOC.com reports UNP Union Pacific $216.16 / -0.51 (-0.24%) 10/22/20 Fly Intel: Pre-market Movers 01/21/21 Union Pacific - UNP UNP Union Pacific $216.16 / -0.51 (-0.24%) 11/10/20 Union Pacific put volume heavy and directionally bearish 08/03/20 Union Pacific put volume heavy and directionally bearish
General news	U.S. industrial production surged 1.6% in December » 09:30 01/15/21 01/15 09:30 01/15/21 09:30 U.S. industrial… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Earnings	Biomerica reports Q2 revenue $1.37M, consensus $2.5M » 09:29 01/15/21 01/15 09:29 01/15/21 09:29 BMRA Biomerica $6.06 / -0.25 (-3.96%) Cash and cash equivalents… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/12/21 Biomerica COVID-19 antigen rapid test receives CE Mark 12/09/20 Biomerica nears completion of enrollment in InFoods IBS DGT trial 09/01/20 Biomerica Inc reports FY20 revenue $6.7M, consensus $5.65M 08/31/20 Biomerica discloses SEC investigation related to COVID-19 Rapid Test samples BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/12/21 B. Riley Securities Biomerica price target lowered to $10 from $11 at B. Riley Securities 11/10/20 Colliers Biomerica initiated with a Buy at Colliers 06/05/20 B. Riley FBR Biomerica price target raised to $11 from $6.25 at B. Riley FBR BMRA Biomerica $6.06 / -0.25 (-3.96%) 10/16/20 Biomerica reports Q1 revenue $1.14M, two est. $1.2M BMRA Biomerica $6.06 / -0.25 (-3.96%) 01/14/21 Biomerica Inc options imply 14.5% move in share price post-earnings 08/28/20 Biomerica Inc options imply 21.1% move in share price post-earnings 07/29/20 Thirteen new option listings on July 29th
Recommendations	NXP Semiconductors price target raised to $209 from $165 at Truist » 09:29 01/15/21 01/15 09:29 01/15/21 09:29 NXPI NXP Semiconductors / + Truist analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NXPI NXP Semiconductors / + 12/09/20 NXP Semiconductors' Owen sells over 7,000 common shares 12/02/20 NXP Semiconductors reports availability of 2nd genreation RF multichip modules 11/25/20 NXP Semiconductors CEO sells 10K shares of common stock 11/25/20 NXP Semiconductors chairman sells 12K shares of common stock NXPI NXP Semiconductors / + 01/06/21 KeyBanc NXP Semiconductors price target raised to $195 from $190 at KeyBanc 12/28/20 Mizuho NXP Semiconductors price target raised to $173 from $155 at Mizuho 12/17/20 KeyBanc NXP Semiconductors price target raised to $190 from $160 at KeyBanc 12/17/20 Deutsche Bank NXP Semiconductors price target raised to $175 from $160 at Deutsche Bank NXPI NXP Semiconductors / + 10/26/20 NXP Semiconductors reports Q3 EPS (8c) vs. 38c a year ago 10/26/20 NXP Semiconductors sees Q4 adjusted operating income $692M-$766M 10/26/20 NXP Semiconductors reports Q3 adj. operating income $586M vs. $687M a year ago 10/26/20 NXP Semiconductors sees Q4 revenue $2.38B-$2.53B, consensus $2.27B NXPI NXP Semiconductors / + 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 10/26/20 Fly Intel: After-Hours Movers 10/09/20 Fly Intel: Wall Street's top stories for Friday 02/02/21 NXP Semiconductors - NXPI NXPI NXP Semiconductors / + 10/01/20 NXP Semiconductors put volume heavy and directionally bearish 09/08/20 NXP Semiconductors put volume heavy and directionally bearish 09/04/20 NXP Semiconductors put volume heavy and directionally bearish 08/27/20 NXP Semiconductors call volume above normal and directionally bullish

Recommendations	Kansas City Southern price target raised to $245 from $210 at Raymond James » 09:29 01/15/21 01/15 09:29 01/15/21 09:29 KSU Kansas City Southern $212.43 / -1.29 (-0.60%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KSU Kansas City Southern $212.43 / -1.29 (-0.60%) 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 12/24/20 North American rail traffic rose 1.9% in week ended December 19 KSU Kansas City Southern $212.43 / -1.29 (-0.60%) 01/12/21 JPMorgan Kansas City Southern price target raised to $204 from $199 at JPMorgan 01/11/21 Citi Kansas City Southern price target raised to $250 from $220 at Citi 12/10/20 Morgan Stanley Morgan Stanley downgrades CSX to Underweight with bar raised too high 11/30/20 Deutsche Bank Kansas City Southern price target raised to $197 from $182 at Deutsche Bank KSU Kansas City Southern $212.43 / -1.29 (-0.60%) 12/03/20 Kansas City Southern says Q4 revenue-to-date down 5% 10/16/20 Kansas City Southern reports Q3 adj. EPS $1.96, consensus $1.90 10/15/20 Notable companies reporting before tomorrow's open 10/15/20 Notable companies reporting before tomorrow's open KSU Kansas City Southern $212.43 / -1.29 (-0.60%) 11/10/20 Kansas City Southern potential bidders have moved on, CNBC reports 09/09/20 Kansas City Southern rejects $20B buyout bid from PE suitors, WSJ says 09/09/20 Kansas City Southern rejects $20B buyout bid from PE suitors, WSJ says 09/02/20 Blackstone, GIP make bid to buy Kansas City Southern, WSJ says KSU Kansas City Southern $212.43 / -1.29 (-0.60%) 09/10/20 Fly Intel: Wall Street's top stories for Thursday 09/10/20 Fly Intel: Wall Street's top stories at midday 09/09/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: Wall Street's top stories for Wednesday 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 01/22/21 Kansas City Southern - KSU KSU Kansas City Southern $212.43 / -1.29 (-0.60%) 07/31/20 Kansas City Southern bid could be valued over $21B with debt, WSJ reports
Recommendations	Generac price target raised to $330 from $260 at Stephens » 09:28 01/15/21 01/15 09:28 01/15/21 09:28 GNRC Generac $252.91 / +0.215 (+0.09%) Stephens analyst Tommy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GNRC Generac $252.91 / +0.215 (+0.09%) 11/10/20 Generac and Milwaukee World Festival announce new partnership 11/03/20 Generac Chairman Aaron Jagdfeld sold over $1M in company shares 10/05/20 Generac acquires Enbala Power Networks, terms undisclosed 09/01/20 Generac division closes acquisition of assets of Mean Green Products GNRC Generac $252.91 / +0.215 (+0.09%) 12/24/20 Roth Capital Roth Capital calls Generac, Sunnova, Enphase favorite 2021 solar ideas 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital 12/15/20 Roth Capital Solar tax credit extension would be positive surprise, says Roth Capital 12/09/20 JPMorgan Generac price target raised to $258 from $235 at JPMorgan GNRC Generac $252.91 / +0.215 (+0.09%) 10/28/20 Generac raises 2020 revenue growth view to 10%-12% from 5%-8%, consensus $2.4B 10/28/20 Generac reports Q3 adjusted EPS $2.08, consensus $1.66 07/30/20 Generac reports Q2 adjusted EPS $1.40, consensus 89c GNRC Generac $252.91 / +0.215 (+0.09%) 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 03/15/21 33rd Annual Roth Virtual Conference 02/11/21 Generac - GNRC
Upgrade	Delta Air Lines upgraded to Buy from Hold at Vertical Research » 09:27 01/15/21 01/15 09:27 01/15/21 09:27 DAL Delta Air Lines $41.46 / +1.03 (+2.55%) Vertical Research… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Delta Air Lines doesn't see Covid-19 testing on domestic flights 01/14/21 Delta Air Lines 'generating a meaningful premium' with blocked middle seats 01/14/21 Delta Air Lines sees 34 aircraft deliveries in 2021, total CapEx of $1.3B 01/14/21 Delta Air Lines sees sustained travel recovery starting in 2H21 DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 07:24 Today Morgan Stanley Delta Air Lines price target raised to $55 from $51 at Morgan Stanley 01/14/21 Fly Intel: Top five analyst downgrades 01/14/21 Susquehanna Susquehanna cuts Delta to Neutral on international and business travel risks 01/14/21 Susquehanna Delta Air Lines downgraded to Neutral from Positive at Susquehanna DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Delta Air Lines sees Q1 revenue down 60%-65%, consensus $4.46B 01/14/21 Delta Air Lines reports Q4 adjusted EPS ($2.53), consensus ($2.51) 01/13/21 Notable companies reporting before tomorrow's open 10/13/20 Delta Air Lines sees Q4 revenue down 65%-70% from last year DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Delta, United, Alaska prohibit guns in checked bags for D.C. flights, AP says 01/12/21 U.S. to expand proof of no COVID rule to all international visitors, WSJ says 01/04/21 Major airlines back expanding COVID testing for more travelers, Reuters reports 01/04/21 Delta CEO sees positive cash flow by spring, AP reports DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/14/21 Fly Intel: Pre-market Movers 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street DAL Delta Air Lines $41.46 / +1.03 (+2.55%) 12/28/20 Delta Air Lines call volume above normal and directionally bullish 09/16/20 Delta Air Lines call volume above normal and directionally bullish 09/15/20 Early notable gainers among liquid option names on September 15th 09/15/20 Unusually active option classes on open September 15th
Upgrade	American Equity upgraded to Outperform from Market Perform at Raymond James » 09:27 01/15/21 01/15 09:27 01/15/21 09:27 AEL American Equity $30.54 / +0.68 (+2.28%) Raymond James analyst C.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly AEL American Equity $30.54 / +0.68 (+2.28%) 01/12/21 American Equity says Tolga Uzuner now CIO Asset Management American Equity 11/16/20 American Equity declares cash dividend of 32c per share, up 6% from prior year 10/29/20 American Equity, Pretium enter expanded strategic partnership 10/19/20 American Equity falls -19.2% AEL American Equity $30.54 / +0.68 (+2.28%) 07:28 Today Raymond James American Equity upgraded to Outperform from Market Perform at Raymond James 01/07/21 B. Riley Securities American Equity upgraded to Buy from Neutral at B. Riley Securities 12/15/20 Credit Suisse American Equity initiated with Outperform, $35 target at Credit Suisse 12/15/20 Credit Suisse American Equity initiated with an Outperform at Credit Suisse AEL American Equity $30.54 / +0.68 (+2.28%) 10/29/20 American Equity reports Q3 EPS ex-items 99c, consensus $1.03 08/05/20 American Equity reports Q2 EPS $1.01, consensus $1.16 AEL American Equity $30.54 / +0.68 (+2.28%) 10/01/20 Athene, MassMutual made over $3B offer for American Equity, WSJ reports AEL American Equity $30.54 / +0.68 (+2.28%) 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers 10/01/20 Fly Intel: Wall Street's top stories at midday
Hot Stocks	Eli Lilly reports $30M limited partner investment in Unseen Capital Health Fund » 09:27 01/15/21 01/15 09:27 01/15/21 09:27 LLY Eli Lilly $186.78 / +1.275 (+0.69%) Eli Lilly and Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $186.78 / +1.275 (+0.69%) 01/11/21 Eli Lilly rises 12.5% 01/11/21 AC Immune, Biogen rise after Lilly reports Alzheimer's study met endpoint 01/11/21 Eli Lilly rises 11.0% 01/11/21 Eli Lilly: FDA accepts sNDA for Jardiance LLY Eli Lilly $186.78 / +1.275 (+0.69%) 01/12/21 Truist Eli Lilly price target raised to $200 from $182 at Truist 01/11/21 JPMorgan Alzheimer's data a 'significant positive' for Eli Lilly story, says JPMorgan 01/11/21 Goldman Sachs Eli Lilly's Alzheimer's trial data a 'positive surprise,' says Goldman Sachs 01/07/21 KeyBanc Veeva initiated with an Overweight at KeyBanc LLY Eli Lilly $186.78 / +1.275 (+0.69%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 LLY Eli Lilly $186.78 / +1.275 (+0.69%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports LLY Eli Lilly $186.78 / +1.275 (+0.69%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Eli Lilly and Alzheimer's research peers jump after study meets endpoint 01/11/21 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 01/29/21 Eli Lilly - LLY LLY Eli Lilly $186.78 / +1.275 (+0.69%) 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th 12/09/20 Unusually active option classes on open December 9th

Events

Earnings calls, analyst events, roadshows and more

Today at 10:00

Business Inventories M/M: November2020 Government Event
Today at 10:00

Consumer Sentiment Index: January(p) 2021 Government Event
WFC
Today at 10:00

Wells Fargo - WFC Conference Calls
CXO
Today at 10:00

Concho Resources, Inc. Firm Sponsored Meetings
COP
Today at 10:00

ConocoPhillips Firm Sponsored Meetings
Today at 10:00

Commercial Real Estate Industry Meetings
ATVI ...
Today at 10:30

Digital Media Industry Meetings
PNC
Today at 11:00

PNC Financial - PNC Conference Calls
Today at 11:30

Fed Reserve Bank President Discusses the Economy Government Event

Virtual Evemt
C
Today at 11:30

Citi - C Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	QLI X QLI Qilian International IPO Managers: Univest Securities, Loop Capital & Alexander Capital Priced at: $5.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGS X MDGS Medigus Secondary Managers: Aegis Priced at: $2.30 3.66M Shares O X O Realty Income Spot Secondary Managers: BofA, Morgan Stanley, Wells Fargo & Citi Priced at: $57.05 10.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSTL X PSTL Postal Realty Trust Spot Secondary Managers: Jefferies, Stifel, BMO Capital & Janney Montgomery Scott Priced at: $15.25 3.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALXO X ALXO ALX Oncology Block Trade Managers: Jefferies Priced at: $82.00 250K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMAB X IMAB I-MAB Block Trade Managers: Jefferies Priced at: $53.00 642K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AFRM X AFRM Affirm IPO Managers: Morgan Stanley, Goldman Sachs & Allen & Co., RBC Capital, Credit Suisse, Barclays, Truist, SIEB, Deutsche Bank Priced at: $49.00 24.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MSGM X MSGM Motorsport Games IPO Managers: Canaccord & Benchmark Priced at: $20.00 3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HCDI X HCDI Harbor Custom Development Secondary Managers: ThinkEquity Priced at: $3.00 8M Shares ZM X ZM Zoom Video Secondary Managers: JPMorgan Priced at: $340.00 5.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AFMD X AFMD Affimed N.V. Spot Secondary Managers: Jefferies, SVB Leerink & Credit Suisse Priced at: $6.00 16.667M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RILY X RILY B. Riley Financial Spot Secondary Managers: B. Riley Securities Priced at: $46.00 1.229M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	POSH X POSH Poshmark IPO Managers: Morgan Stanley, Goldman Sachs & Barclays, Stifel, William Blair, Raymond James, Cowen, JMP Securities Priced at: $42.00 6.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial WOOF X WOOF Petco IPO Managers: Goldman Sachs & BofA, Citi, Evercore ISI, Credit Suisse, UBS, Wells Fargo, Baird, Guggenheim, AmeriVet, CL King, R. Seelaus, Ramirez, SIEB Priced at: $18.00 48M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LMND X LMND Lemonade Secondary Managers: Goldman Sachs, Morgan Stanley, Allen & Co. & Barclays Priced at: $165.00 4.524M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PRVB X PRVB Provention Bio Secondary Managers: SVB Leerink & Cantor Fitzgerald Priced at: $16.00 6.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RPAY X RPAY Repay Holdings Secondary Managers: Credit Suisse & Barclays, Citi, Truist Priced at: $24.00 5.43M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VNT X VNT Vontier Secondary Managers: Goldman Sachs, Citi & Evercore ISI, JPMorgan, Morgan Stanley, Credit Suisse, UBS, Baird Priced at: $33.50 33.507M Shares ALDX X ALDX Aldeyra Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $9.50 6.842M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVOK X EVOK Evoke Pharma Spot Secondary Managers: Laidlaw Priced at: $2.50 5M Shares
Thurs	DRVN X DRVN Driven Brands IPO Managers: Morgan Stanley, BofA, Goldman Sachs, JPMorgan & Barclays, Credit Suisse, Baird, Piper Sandler, William Blair Priced at: $22.00 31.8M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KUKE X KUKE Kuke Music IPO Managers: Deutsche Bank, Tigress Financial, AMTD & China International, Valuable Capital Priced at: $10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLTK X PLTK Playtika IPO Managers: Morgan Stanley, Credit Suisse, Citi, Goldman Sachs, UBS & BofA, Baird, Cowen, Stifel, Wedbush Priced at: $27.00 69.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMWL X AMWL Amwell Secondary Managers: Morgan Stanley, Goldman Sachs, Piper Sandler & UBS, Credit Suisse, Cowen, Berenberg Priced at: $27.50 11.281M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Secondary Managers: Maxim Priced at: $.55 26.182M Shares LTRN X LTRN Lantern Pharma Spot Secondary Managers: ThinkEquity Priced at: $14.00 4.28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley $10.90-11.10 20M Shares
Fri	No deals

View All Syndicate Announcements »

Lennox downgraded to Equal Weight on valuation at Barclays

TODAY'S FREE FLY STORIES

Get Full Fly Access